Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and Metabolism-Reference-Cited by-同舟云学术

Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and Metabolism

Published:2007-10 Issue:10 Volume:48 Page:1850-1860
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Nissen-Meyer Lise Sofie H.,Svalheim Sigrid,Taubøll Erik,Reppe Sjur,Lekva Tove,Solberg Lene B.,Melhus Gunhild,Reinholt Finn P.,Gjerstad Leif,Jemtland Rune

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1528-1167.2007.01176.x/fullpdf

Reference60 articles.

1. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus

2. Benefit-Risk Assessment of Levetiracetam in the Treatment of Partial Seizures

3. Antiepileptic Drug–Induced Bone Loss in Young Male Patients Who Have Seizures

4. Use of levetiracetam in treating epilepsy associated with other medical conditions

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epilepsy and Anti-Seizure Medications: Secret Agents for Endocrine Disruption;Epilepsy Currents;2023-12-06

2. A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy;CNS Drugs;2023-11

3. GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification;Journal of Investigative Dermatology;2023-10

4. Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement;Pharmaceutics;2023-09-18

5. Relationship between bone density and levetiracetam monotherapy in epilepsy patients;Clinical Neurology and Neurosurgery;2022-07